Janus Henderson Investors US’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$129M Buy
832,214
+331,096
+66% +$45.6M 0.11% 244
2016
Q4
$58.8M Buy
501,118
+179,473
+56% +$20.5M 0.05% 404
2016
Q3
$36.3M Buy
321,645
+254,519
+379% +$26.8M 0.03% 490
2016
Q2
$6.23M Buy
67,126
+62,126
+1,243% +$5.34M 0.01% 740
2016
Q1
$392K Sell
5,000
-394,139
-99% -$28.4M ﹤0.01% 1082
2015
Q4
$29.1M Sell
399,139
-2,305
-0.6% -$164K 0.02% 542
2015
Q3
$29.8M Sell
401,444
-65,290
-14% -$4.68M 0.03% 519
2015
Q2
$29.9M Sell
466,734
-109,756
-19% -$7.6M 0.02% 537
2015
Q1
$44.5M Sell
576,490
-652,508
-53% -$50.8M 0.04% 473
2014
Q4
$91.1M Sell
1,228,998
-497,376
-29% -$34.9M 0.08% 324
2014
Q3
$102M Sell
1,726,374
-146,226
-8% -$9.25M 0.09% 263
2014
Q2
$125M Buy
1,872,600
+249,000
+15% +$15.8M 0.11% 225
2014
Q1
$98.6M Buy
1,623,600
+88,122
+6% +$5.25M 0.09% 274
2013
Q4
$81.7M Buy
1,535,478
+1,514
+0.1% +$79.7K 0.08% 302
2013
Q3
$76.4M Sell
1,533,964
-7,994
-0.5% -$384K 0.08% 292
2013
Q2
$69.2M Buy
+1,541,958
New +$67.4M 0.07% 301

Other funds holding IDXX

Janus Henderson Investors US's IDXX Position: Q1 2017 in Review

Janus Henderson Investors US increased its Idexx Laboratories (IDXX) stake by 66% in Q1 2017, buying an estimated $45.6M and bringing the position to 832,214 shares worth $129M. The position accounts for 0.11% of the portfolio, ranked #244.

Janus Henderson Investors US first reported a position in IDXX in Q2 2013 and has held it in 16 quarters since. 542 funds tracked by Wall St. Rank hold IDXX as of Q1 2017.

  • Janus Henderson Investors US held 832,214 shares of Idexx Laboratories worth $129M as of Q1 2017.
  • Janus Henderson Investors US bought 331,096 Idexx Laboratories shares in Q1 2017, an estimated $45.6M.
  • Idexx Laboratories made up 0.11% of Janus Henderson Investors US's portfolio in Q1 2017, its #244 holding.
  • Janus Henderson Investors US first reported a position in Idexx Laboratories in Q2 2013 and has held it in 16 quarters since.
  • 542 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.